glp-1 medications and anesthesia Updated guidance for patients using GLP-1/GIP receptor agonists GLP-1 medication and its types
Description
Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV study
completed a retrospective study on patients undergoing elective EGD, done in 2023
Stronger options can support both weight loss and diabetes prevention
PMID 32564337
These medications help regulate blood sugar levels and reduce appetite
Your work has been incredible and a cornerstone in my life
